Global Alzheimers Drugs Market Analysis 2014-2017 & Forecast to 2022 by Drug Class, Distribution Channel and Region - ResearchAndMarkets.com

DUBLIN--()--The "Alzheimers Drugs Market by Drug Class , by Distribution Channel , and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022" report has been added to ResearchAndMarkets.com's offering.

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along with the impact they have on the demand over the forecast period.

Additionally, the report includes the study of opportunities available in the Alzheimers drugs market on a global level. In order to give the users of this report a comprehensive view on the Alzheimers drugs market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses drug class, distribution channel and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

Market Dynamics

Drivers

  • Growing Occurrence of Diseases in Developed Western Countries
  • Steady Government Support for Alzheimers Drug Development, Growing Awareness About Treatment of Alzheimers Disease

Restraints

  • High Prices of Advanced Drugs
  • Awareness About Alzheimers Disease Remains Limited in Developing Countries Like Southeast Asia

Opportunities

  • Growing Support for Mental Care Infrastructure from Governments in Several Developing Asia-Pacific Countries is Thus Likely to Drive the Alzheimers Drugs Market in the Region in the Coming Years

Companies Mentioned

  • Ono Pharmaceutical
  • Johnson Johnson
  • Daiichi Sankyo Company Limited
  • H Lundbeck A/S
  • Eisai Co Ltd.

Key Topics Covered

1. Introduction

2. Executive Summary

3. Alzheimers Drugs Market Dynamics

4. Global Alzheimers Drugs Market Competitive Landscape

5. Global Alzheimers Drugs Market Drug Class Segment Analysis

5.1. Global Alzheimers Drugs Market: Drug Class Overview

5.2. Cholinergic

5.3. Memantine

5.4. Combined Drug

6. Global Alzheimers Drugs Market Distribution Channel Segment Analysis

6.1. Global Alzheimers Drugs Market: Distribution Channel Overview

6.2. Hospital Pharmacy

6.3. Retail Pharmacy

6.4. Online Sales

7. Global Alzheimers Drugs Market Regional Segment Analysis

7.1. Global Alzheimers Drugs Market: Regional Overview

7.2. North America

7.3. Europe

7.4. Asia-Pacific

7.5. Latin America

7.6. Middle East and Africa

8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/b35vwg/global_alzheimers?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Alzheimer's Disease Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Alzheimer's Disease Drugs